T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
2351
DELISTED
NxStage Medical Inc.
NXTM
| $217K | ﹤0.01% |
8,275
-25
| -0.3% | -$618 |
|
2352
RGC Resources
RGCO
$225M
| $216K | ﹤0.01% |
12,879
| – | – |
|
|
LQ
2353
DELISTED
La Quinta Holdings Inc.
LQ
| $215K | ﹤0.01% |
15,140
-34,300
| -69% | -$407K |
|
|
AXAS
2354
DELISTED
Abraxas Petroleum Corp
AXAS
| $214K | ﹤0.01% |
4,170
| – | – |
|
|
GNC
2355
DELISTED
GNC Holdings, Inc.
GNC
| $214K | ﹤0.01% |
19,353
-17,265
| -47% | -$270K |
|
2356
iShares MSCI South Korea ETF
EWY
$27.2B
| $213K | ﹤0.01% |
4,000
-2,202
| -36% | -$120K |
|
2357
Lands' End
LE
$391M
| $213K | ﹤0.01% |
14,068
-5,762
| -29% | -$94.2K |
|
|
CSII
2358
DELISTED
Cardiovascular Systems, Inc.
CSII
| $213K | ﹤0.01% |
8,800
| – | – |
|
2359
LeMaitre Vascular
LMAT
$1.88B
| $211K | ﹤0.01% |
+8,337
| New | +$185K |
|
|
GHDX
2360
DELISTED
Genomic Health, Inc.
GHDX
| $210K | ﹤0.01% |
7,160
+230
| +3% | +$7.01K |
|
2361
Agilysys
AGYS
$3.03B
| $209K | ﹤0.01% |
20,194
| – | – |
|
|
CTO
2362
CTO Realty Growth
CTO
$819M
| $209K | ﹤0.01% |
14,404
| – | – |
|
|
ARNA
2363
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $209K | ﹤0.01% |
14,730
+9,500
| +182% | +$147K |
|
2364
AerCap
AER
$23.6B
| $208K | ﹤0.01% |
+5,000
| New | +$210K |
|
2365
Franklin Covey
FC
$234M
| $208K | ﹤0.01% |
10,332
| – | – |
|
2366
Carriage Services
CSV
$535M
| $207K | ﹤0.01% |
+7,240
| New | +$188K |
|
|
GES
2367
DELISTED
Guess Inc
GES
| $207K | ﹤0.01% |
17,089
-31
| -0.2% | -$435 |
|
|
DS
2368
DELISTED
Drive Shack Inc.
DS
| $207K | ﹤0.01% |
55,150
| – | – |
|
2369
RadNet
RDNT
$6.06B
| $206K | ﹤0.01% |
32,000
| – | – |
|
|
HTO
2370
H2O America
HTO
$2.62B
| $204K | ﹤0.01% |
+3,640
| New | +$184K |
|
|
LOXO
2371
DELISTED
Loxo Oncology, Inc
LOXO
| $204K | ﹤0.01% |
6,337
-26,826
| -81% | -$688K |
|
|
HRG
2372
DELISTED
HRG Group, Inc.
HRG
| $203K | ﹤0.01% |
13,027
-43
| -0.3% | -$657 |
|
2373
Independence Realty Trust
IRT
$3.96B
| $199K | ﹤0.01% |
22,347
+57
| +0.3% | +$493 |
|
|
STRR
2374
DELISTED
Star Equity Holdings
STRR
| $198K | ﹤0.01% |
792
| – | – |
|
2375
GoPro
GPRO
$106M
| $196K | ﹤0.01% |
22,515
-16,400
| -42% | -$188K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.